|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―May―22 |
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) |
Surya K. De |
2 |
[GO] |
2023―May―16 |
Long COVID-19 syndrome and sudden cardiac death: the phantom menace |
Michael Spartalis, David Zweiker, Eleftherios Spartalis, Dimitrios C. Iliopoulos, Gerasimos Siasos |
3 |
[GO] |
2023―May―16 |
The impact of lncRNA-GAS5/miRNA-200/ACE2 molecular pathway on the severity of COVID-19 |
Amr M. Abdelhamid, Ghada Ayeldeen, Olfat G. Shaker, Eman Amer, Mai A. Zaafan, Mohamed R. Herzalla, Mofida A. Keshk |
4 |
[GO] |
2023―May―05 |
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human coronavirus, and Enteroviruses |
Surya K. De |
5 |
[GO] |
2023―May―04 |
Hydrogen sulfide: physiological roles and therapeutic implications against COVID-19 |
Amirhossein Sahebkar, Sajad Abolfazli, Nima Ebrahimi, Eftekhar Morabi, Mohammad Amin Asgari Yazdi, Gokhan Zengin, et al. (+2) Thozhukat Sathyapalan, Tannaz Jamialahmadi |
6 |
[GO] |
2023―Apr―09 |
Perspectives and Prospects on the application of DNA Aptamer in SARS-CoV-2 |
Xiaoxiao Hu, Yunyi Liu, Bei Hu, Xiaming Pei, Juan Li |
7 |
[GO] |
2023―Mar―31 |
SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19 |
Ligen Yu, Mohd Khanapi Abd Ghani, Alessio Aghemo, Debmalya Barh, Matteo Bassetti, Fausto Catena, et al. (+12) Gaetano Gallo, Ali Gholamrezanezhad, Mohammad Amjad Kamal, Amos Lal, Kamal Kant Sahu, Shailendra K Saxena, Ugo Elmore, Farid Rahimi, Chiara Robba, Yuanlin Song, Zhengyuan Xia, Boxuan Yu |
8 |
[GO] |
2023―Mar―31 |
Traditional Chinese Medicine as the preventive and therapeutic remedy for COVID-19 |
Geir Bjørklund, Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Alain Menzel, Roman Lysiuk, et al. (+3) Mariia Shanaida, Larysa Lenchyk, Massimiliano Peana |
9 |
[GO] |
2023―Feb―24 |
Sleep, dietary melatonin supplementation, and COVID-19 |
Geir Bjørklund, Amin Gasmi, Yuliya Semenova, Sadaf Noor, Asma Gasmi Benahmed |
10 |
[GO] |
2023―Feb―23 |
Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity |
Amirhossein Sahebkar, Sepideh Karkon Shayan, Elham Nasrollahi, Yaser Bahramvand, Mahdi Zarei, Ahmadreza Atarodi, et al. (+6) Yeganeh Farsi, Mitra Tavakolizadeh, Milad Shirvaliloo, Mitra Abbasifard, Tannaz Jamialahmadi, Maciej Banach |
11 |
[GO] |
2023―Feb―06 |
Is BMI Associated with Covid-19 Severity? A Retrospective Observational Study |
Marcello Candelli, Giulia Pignataro, Angela Saviano, Veronica Ojetti, Maurizio Gabrielli, Andrea Piccioni, et al. (+4) Antonio Gullì, Massimo Antonelli, Antonio Gasbarrini, Francesco Franceschi |
12 |
[GO] |
2022―Dec―07 |
The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19 |
Ilias Giannakodimos |
13 |
[GO] |
2022―Dec―07 |
Current Scenario and Future Prospect in the Management of COVID-19 |
Pobitra Borah |
14 |
[GO] |
2022―Dec―07 |
The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis |
Stamatios Lampsas |
15 |
[GO] |
2022―Dec―07 |
The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic |
Rajesh Kumar |
16 |
[GO] |
2022―Dec―07 |
Targeting COVID-19 in Parkinsons Patients: Drugs Repurposed |
Firoz Anwar |
17 |
[GO] |
2022―Dec―07 |
COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed |
Mercedes Jimenez |
18 |
[GO] |
2022―Dec―07 |
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection |
Michele Costanzo |
19 |
[GO] |
2022―Dec―07 |
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp) |
Shabana Bibi |
20 |
[GO] |
2022―Oct―18 |
Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed |
Firoz Anwar |
21 |
[GO] |
2022―Oct―18 |
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus |
Michele Costanzo |
22 |
[GO] |
2022―Oct―18 |
In Vitro Data of Current Therapies for SARS-CoV-2 |
Ioanna Anastasiou |
23 |
[GO] |
2022―Oct―05 |
COVID-19 and Alzheimer's Disease:
Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved |
Alicia B. Pomilio, Arturo A. Vitale, Alberto J. Lazarowski |
24 |
[GO] |
2022―Oct―05 |
Looking for SARS-CoV-2 therapeutics through computational approaches |
Marilisa Leone, Marian Vincenzi, Flavia Anna Mercurio |
25 |
[GO] |
2022―Sep―23 |
Novel Proline derivatives for Treating COVID-19 |
Surya K. De |
26 |
[GO] |
2022―Sep―06 |
Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS |
Seyed Mohammad Nabavi, Aysa Rezabakhsh, Seyed Fazel Nabavi, Adeleh Sahebnasagh, Ahad Shahbazi, Mojde Rahmani, et al. (+8) Saeid Azimi, Malihe Khayat kashani, Solomon Habtemariam, Mohadese Badiee, Javad Hashemi, Fatemeh Saghafi, Kiumarth Amini, Mina Azimi |
27 |
[GO] |
2022―Aug―30 |
Cannabinoids receptors in Covid-19: Perpetrators and victims |
Athanasios Alexiou, Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb |
28 |
[GO] |
2022―Jul―28 |
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus |
|
29 |
[GO] |
2022―Jul―04 |
Imaging markers of neurologic damage in COVID-19: a systematic review |
Sara Tavares Araújo, Clara Tavares Araújo, Rafael Silva e Castro, Lara Machado de Oliveira Brügger, Nathália Gualberto Souza e Silva, Debora Marques de Miranda, Ana Cristina Simões e Silva |
30 |
[GO] |
2022―Jun―28 |
Review on In silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2.. |
Yuksel Cetin, Seyma Aydinlik, Aysen Gungor, Tugce Kan, Timucin Avsar, Serdar Durdagi |
31 |
[GO] |
2022―May―07 |
Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on pandemic COVID-19 |
Tiziana Mundula, Edda Russo, Lavinia Curini, Francesco Giudici, Andrea Piccioni, Francesco Franceschi, Amedeo Amedei |
32 |
[GO] |
2022―Mar―02 |
COVID-19 Effects on Geriatric Populationand Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccinesin the Prevention & Treatment of COVID-19 |
Narasimha M. Beeraka, SubbaRao V Tulimilli, M V Greeshma, Siva Dallavalasa, Yaowen Zhang, Wenjing Xiao, et al. (+6) Ruitai Fan, Di Zhao, Anjali Devi S. Bettadapura, Suma M. Natraj, SubbaRao V Madhunapantula, Junqi Liu |
33 |
[GO] |
2022―Feb―16 |
Perspectives and Prospects on mRNA Vaccine
Development for COVID-19 |
Lihui Jin, Zhenyuan Han, Pengjun Zhao, Kun Sun |
34 |
[GO] |
2022―Feb―14 |
Aptamer-based Emerging Tools for Viral Biomarker Detection: A focus on SARS-CoV-2 |
Prabir Kumar Kulabhusan, Parsa Pishva, Eda Çapkın, Prajakta Tambe, Meral Yüce |
35 |
[GO] |
2021―Oct―27 |
The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis |
Stamatios Lampsas, Paraskevas Tsaplaris, Panteleimon Pantelidis, Evangelos Oikonomou, Georgios Marinos, Georgios Charalambous, et al. (+9) Nektarios Souvaliotis, Vasiliki-Chara Mystakidi, Athina Goliopoulou, Efstratios Katsianos, Gerasimos Siasos, Michael-Andrew Vavuranakis, Costas Tsioufis, Manolis Vavuranakis, Dimitrios Tousoulis |
36 |
[GO] |
2021―Sep―02 |
The impact of Vaccination worldwide on SARS-CoV-2 infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants |
Douglas Henrique Pereira Damasceno, Arthur Aguiar Amaral, Cecília Andrade Silva, Ana Cristina Simões e Silva |
37 |
[GO] |
2021―Aug―23 |
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) |
Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos, Hong Yu |
38 |
[GO] |
2021―Jul―27 |
Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2 |
Luana N. O. Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S. S. Neto, Carlos V. D. dos Santos, et al. (+8) Maryelle G. de Carvalho, Eduardo M. Dalmarco, Leonardo B. Turqueti, Marcus Tullius Scotti, Luciana Scotti, Francisco F. de Assis, Antonio Braga, Louis Pergaud Sandjo |
39 |
[GO] |
2021―Jun―24 |
Interfering Reactive Cysteine Proteome in Covid-19 Disease |
Marcos Martinez-Banaclocha |
40 |
[GO] |
2021―Jun―15 |
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects |
Davide Gentile, Vincenzo Patamia, Virginia Fuochi, Pio M. Furneri, Antonio Rescifina |
41 |
[GO] |
2021―May―27 |
COVID-19: The significance of platelets, mitochondria, vitamin D, serotonin and the gut microbiota |
István Bókkon, Gábor Kapócs, András Vucskits, Attila Erdöfi-Szabó, Jan Vagedes, Felix Scholkman, Henrik Szőke |
42 |
[GO] |
2021―May―27 |
Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy |
Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Knaff, Volker Mailänder, Tanja Schirmeister, Christian Kersten |
43 |
[GO] |
2021―May―22 |
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection |
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello |
44 |
[GO] |
2021―May―10 |
SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies |
Zhao-Zhong Chong, Nizar Souayah |
45 |
[GO] |
2021―May―05 |
Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics |
Rahul Sharma, Dharmendra Khokhar, Bhanushree Gupta, Purnendu Saxena, Kallol Kumar Ghosh, Arvind Kumar Geda, Kamil Kuca |
46 |
[GO] |
2021―Apr―06 |
The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis |
Alice Barros Câmara, Igor Augusto Brandão |
47 |
[GO] |
2021―Mar―30 |
Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2 |
Walter Filgueira de Azevedo Junior, Gabriela Bitencourt-Ferreira, Joana Retzke Godoy, Hilda Mayela Aran Adriano, Wallyson André dos Santos Bezerra, Alexandra Martins dos Santos Soares |
48 |
[GO] |
2021―Feb―19 |
Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses |
Sathish Veerasamy, Manivannan Chandrakumar, Malathi Balasubramaniyan, Ramesh Kumar Arumugam, Thanasekaran Pounraj |
49 |
[GO] |
2021―Feb―15 |
Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19 |
Katharina Lanza, Raphael Dias, Rafaela dos Santos Oliveira, Luís Belotto, Aline Silva Miranda, Ana Cristina Simões e Silva |
50 |
[GO] |
2021―Feb―10 |
Nucleoside Inhibitors of Coronaviruses |
Anastasia A. Zenchenko, Mikhail S. Drenichev, Sergey N. Mikhailov |
51 |
[GO] |
2021―Jan―26 |
Natural Products as Potential Agents Against SARS-CoV and SARS-CoV-2 |
Joanda Paolla Raimundo e Silva, Chonny Alexander Herrera Acevedo, Thalisson Amorim de Souza, Renata Priscila Barros de Menezes, Zoe L. Sessions, Lucas Silva Abreu, et al. (+6) Samuel Paulo Cibulski, Luciana Scotti, Marcelo Sobral da Silva, Eugene N. Muratov, Marcus Tullius Scotti, Josean Fechine Tavares |
52 |
[GO] |
2021―Jan―14 |
Deep learning in the quest for compound nomination for fighting COVID-19 |
Maria Mernea, Eliza. C. Martin, Andrei-José Petrescu, Speranta Avram |
53 |
[GO] |
2021―Jan―08 |
Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19 |
Sumera Zaib, Nehal Rana, Areeba Noor, Imtiaz Khan |
54 |
[GO] |
2020―Dec―10 |
The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19 |
Ilias Giannakodimos, Georgia-Vasiliki Gkountana, Dimosthenis Lykouras, Kiriakos Karkoulias, Sotiris Tsakas |
55 |
[GO] |
2020―Oct―28 |
COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed. |
Nuria E. Campillo, Mercedes Jimenez, Matilde Canelles |
56 |
[GO] |
2020―Oct―28 |
COVID-19: innovative antiviral drugs required for long-term prevention and control of coronavirus diseases |
Norman A. Ratcliffe, Helena C. Castro, Izabel C. Paixão, Cicero B. Mello |
57 |
[GO] |
2020―Oct―28 |
Recent Advances towards Drug Design Targeting the Protease of 2019 novel coronavirus (2019-nCoV) |
Sehrish Bano, Abdul Hameed, Mariya Al-Rashida, Shafia Iftikhar, Jamshed Iqbal |
58 |
[GO] |
2020―Oct―27 |
Evidence and the main adverse effects regarding drug therapies in the war against COVID-19 |
Mauricio Mora-Ramírez, Paulina Melgoza-Hernández, Sebastian Eduardo Toledo-Ramírez, Juan Manuel Mejía Aranguré |
59 |
[GO] |
2020―Oct―06 |
COVID-19 related coagulopathy: what is known up to now |
Ana Luísa Batista Pena, Rafael Arantes Oliveira, Renata Gomes Severo, Ana Cristina Simões e Silva |
60 |
[GO] |
2020―Sep―09 |
Current scenario and future prospect in the management of COVID-19 |
Pobitra Borah, Pran Kishore Deb, Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, et al. (+2) Kiran Kalia, Rakesh Kumar Tekade |
61 |
[GO] |
2020―Sep―05 |
Targeting COVID-19 in Parkinson’s patients: Drugs repurposed. |
Firoz Anwar, Salma Naqvi, Fahad A. Al-Abbasi, Nauroz Neelofar, Vikas Kumar, Ankit Sahoo, Mohammad Amjad Kamal |
62 |
[GO] |
2020―Sep―03 |
Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19 |
Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Cristina Cerqueira Vieira, Lucas Crepaldi Carvalho Nery, Raphael Figuiredo Dias, Ana Cristina Simões e Silva |
63 |
[GO] |
2020―Jul―22 |
Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19 |
Mark Laws, Yasmin M. Surani, Md. Mahbub Hasan, Yiyuan Chen, Peiqin Jin, Taha AlAdhami, et al. (+6) Madiha Chowdhury, Aqeel Imran, Ioannis Psaltis, Shirin Jamshidi, Kazi S. Nahar, Khondaker Miraz Rahman |
64 |
[GO] |
2020―Jul―11 |
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions |
Anil K. Sharma, Varruchi Sharma, Arun Sharma, Suresh Pallikkuth |
65 |
[GO] |
2020―Jul―02 |
The chronicle of COVID-19: possible strategies to curb the pandemic |
Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori, Bijo Mathew |
66 |
[GO] |
2020―May―13 |
In vitro data of current therapies for SARS-CoV-2 |
Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Dimitrios Tsilingiris, Nikolaos Tentolouris |
67 |
[GO] |
2020―Apr―16 |
SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus |
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello |